Eli Lilly said on Thursday it sued the federal Health Resources and Services Administration (HRSA) over allegedly blocking ...

A phase 2b, long-term extension, dose-ranging study of oral JNJ-77242113 for the treatment of moderate-to-severe plaque psoriasis,” published in the November 2024 issue of Dermatology by Ferris et al.

Eli Lilly (LLY) files lawsuit against U.S. health agency over 340B Program rebates, alleging arbitrary blockage of its cash ...

Eli Lilly sued the Health Resources and Services Administration (HRSA) for allegedly blocking the pharma giant's proposal to ...

The popular at-home red light therapy skincare treatment uses low-level wavelengths of red light to address various skin ...

Alumis Inc. ( (ALMS) ) has released its Q3 earnings. Here is a breakdown of the information Alumis Inc. presented to its investors. Alumis ...

MALVERN, Pa., Nov. 15, 2024 /PRNewswire/ -- Endo, Inc. (OTCQX: NDOI ) announced today that it has entered into a definitive agreement with MC2 Therapeutics ("MC2") to commercialize Wynzora® Cream ...

Analyst Terence Flynn from Morgan Stanley maintained a Hold rating on Biogen (BIIB – Research Report) and keeping the price target at ...

Winter itch is a common and discomforting cold weather problem, but some simple lifestyle changes can help to take care of the itch and prevent your skin from such issues.

Research analysts at HC Wainwright increased their FY2024 earnings per share (EPS) estimates for shares of FibroBiologics in a research note issued to investors on Wednesday, November 13th. HC ...

At the start of 2023, U.S. patent exclusivity expired for the blockbuster drug Humira, AbbVie's chief cash cow. During the 20 ...